The 3 randomly selected alternative splicing genes (URI1, MTMR14 and BPTF) were further validated by qPCR in HCC clinical samples and alternative splicing events of these three genes are significantly changed (p < 0.001). The gene discussed is MTMR14; the disease is hepatocellular carcinoma.